CINA CHEST vs Libby Echo:Prio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CINA CHEST

by Avicenna.AI

Libby Echo:Prio

by Dyad Medical

AI Verdict

CINA CHEST is designed for rapid triage of acute, life-threatening conditions like Pulmonary Embolism and Aortic Dissection using CT angiography scans. In contrast, Libby Echo:Prio provides AI-powered analysis and decision support for cardiac function quantification based on echocardiogram images. While both are cardiology AI tools, their distinct imaging modalities and clinical applications make them suitable for different diagnostic workflows.

Choose CINA CHEST if…

Choose CINA CHEST if your emergency department or radiology practice requires immediate AI-powered triage for life-threatening chest conditions. This tool is ideal for rapidly detecting and prioritizing suspected Pulmonary Embolism or Aortic Dissection on CT angiography scans, ensuring critical cases are flagged quickly within your workflow.

View CINA CHEST →

Choose Libby Echo:Prio if…

Choose Libby Echo:Prio if your cardiology department needs an AI-powered solution for consistent and efficient echocardiogram analysis. This cloud-based platform is best suited for automating cardiac measurements and providing data-driven decision support, enhancing the accuracy and speed of cardiac function quantification.

View Libby Echo:Prio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CINA CHEST	Libby Echo:Prio
Pricing	Subscription-based	Custom
Deployment	CINA runs on the AVI Platform or a third-party platform, between your scanner and your PACS. Results simply appear as an additional series, with an alert when a finding is positive for one of the pathologies CINA detects.	Cloud-based
BAA Available	Unknown	No AI-estimated
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	No AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CINA CHEST

CINA CHEST offers greater deployment flexibility, supporting cloud, on-premise, and virtualized environments, which caters to diverse hospital IT infrastructures. Its design as a standalone web application with notifications and 'Plug & Read' integration into CT scan workflows emphasizes seamless user experience and adaptability within existing clinical settings.

Clinical Value

CINA CHEST

CINA CHEST provides critical, rapid triage and notification for life-threatening conditions like Pulmonary Embolism and Aortic Dissection, directly impacting emergency patient outcomes by improving diagnostic efficiency and prioritization for radiologists. The availability of specific clinical validation studies demonstrating its performance and impact further solidifies its clinical value.

Pricing & Value

Tie

Both tools lack transparent public pricing, requiring direct vendor contact for details. While CINA CHEST indicates a 'subscription-based' model and some related Avicenna.AI products detail pricing based on analyses or installations, Libby Echo:Prio only states 'custom' pricing, making a direct comparison of value impossible without further information.

Enterprise Readiness

CINA CHEST

CINA CHEST demonstrates superior enterprise readiness with explicit HIPAA compliance and the likelihood of a Business Associate Agreement (BAA), which are fundamental for healthcare data security and regulatory adherence. Furthermore, its flexible deployment options (cloud, on-premise, virtualized) cater to a broader range of institutional IT requirements, unlike Libby Echo:Prio's stated lack of HIPAA compliance and sole cloud deployment.

Innovation

CINA CHEST

CINA CHEST demonstrates a broader and more impactful innovation by applying deep learning for rapid triage of multiple life-threatening conditions in emergency radiology, aiming to accelerate critical decision-making and improve patient outcomes. Avicenna.AI's continuous development of a comprehensive suite of AI tools across various emergency imaging scenarios further highlights its innovative drive and wider scope.

Support & Docs

Tie

Both companies provide basic contact information for inquiries. However, neither the structured facts nor the web search results offer specific details regarding dedicated support channels, service level agreements, or comprehensive public documentation for either product, making it impossible to distinguish their support and documentation offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CINA CHEST	Libby Echo:Prio
Name	CINA CHEST	Libby Echo:Prio
Company	Avicenna.AI	Dyad Medical
Description	FDA-cleared AI-powered radiological triage and notification software by Avicenna.AI, designed for the rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans.	FDA-cleared, cloud-based AI platform for fast, data-driven echocardiogram analysis, providing decision support and automated cardiac measurements for clinicians.
Key Functionality	Radiological computer-aided triage and notification; Detection of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography; Flags and communicates suspected positive findings.	AI-powered cardiac image analysis; Fast, data-driven echocardiogram image analysis; Decision-making support for cardiac function quantification; Automated estimation of cardiac measurements.
Specialties	Cardiology, Emergency Medicine, Radiology	Cardiology, Critical Care, Radiology

Videos

Demos, reviews, and walkthroughs featuring CINA CHEST and Libby Echo:Prio.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific medical conditions and imaging modalities do these AI tools target?

CINA CHEST is designed for the rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans. Libby Echo:Prio focuses on fast, data-driven echocardiogram analysis, providing decision support and automated cardiac measurements for clinicians.

How do these tools integrate into existing clinical workflows?

CINA CHEST assists hospital networks and trained radiologists in workflow triage by flagging and communicating suspected positive findings, providing notifications with compressed preview images. Libby Echo:Prio is embedded in existing clinical workflows to provide fast analysis, decision-making support for cardiac function quantification, automated measurements, and an immediately-available second opinion.

What are the specific FDA clearances for each product?

CINA CHEST has received FDA 510(k) clearance K210237. Libby Echo:Prio has also received FDA 510(k) clearance, specifically K220956.

What kind of output or assistance do these tools provide to clinicians?

CINA CHEST provides radiological computer-aided triage and notification, detecting PE and AD and flagging suspected positive findings to assist in workflow prioritization. Libby Echo:Prio offers AI-powered cardiac image analysis, automated estimation of cardiac measurements, and decision-making support for cardiac function quantification, acting as an immediately-available second opinion.